Brokerages Set Blueprint Medicines Co. (NASDAQ:BPMC) Price Target at $125.38
Shares of Blueprint Medicines Co. (NASDAQ:BPMC – Get Free Report) have earned an average rating of “Hold” from the twenty-two brokerages that are covering the company, MarketBeat reports. Sixteen research analysts have rated the stock with a hold recommendation, five have issued a buy recommendation and one has given a strong buy recommendation to the […]
Shares of Blueprint Medicines Co. (NASDAQ:BPMC – Get Free Report) have earned an average rating of “Hold” from the twenty-two brokerages that are covering the company, MarketBeat reports. Sixteen research analysts have rated the stock with a hold recommendation, five have issued a buy recommendation and one has given a strong buy recommendation to the […]
